# EOM Pharmaceuticals Holdings, Inc. (IMUC)

> Healthcare · US · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/IMUC/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2022 | $ 0 | $ -2.96M | $ -769.1K | $ 3.47M | $ -4.19M |
| 2021 | $ 0 | $ -1.20M | $ -705.8K | $ 2.82M | $ -1.62M |
| 2020 | $ 0 | $ -2.3K | $ -1.6K | $ 0 | $ 129.6K |
| 2018 | $ 0 | $ -1.76M | $ -4.99M | $ 0 | $ 3.43M |
| 2017 | $ 0 | $ -19.12M | $ -22.46M | $ 0 | $ 4.65M |
| 2016 | $ 0 | $ -30.39M | $ -27.34M | $ 0 | $ 6.13M |
| 2015 | $ 0 | $ -17.96M | $ -26.97M | $ 0 | $ 21.72M |
| 2014 | $ 0 | $ -13.25M | $ -14.08M | $ 0 | $ 23.29M |
| 2013 | $ 0 | $ -12.52M | $ -12.56M | $ 0 | $ 26.47M |
| 2012 | $ 0 | $ -20.93M | $ -17.89M | $ 0 | $ 23.07M |
| 2011 | $ -155.1K | $ -8.40M | $ -9.50M | $ 0 | $ 3.23M |
| 2010 | $ -4.9K | $ -9.31M | $ -6.44M | $ 0 | $ 2.34M |
| 2009 | $ -37.8K | $ -3.98M | $ -3.26M | $ 0 | $ 1.10M |
| 2008 | $ -8.2K | $ -4.63M | $ -2.96M | $ 0 | $ 2.94M |
| 2007 | $ -5.6K | $ -5.47M | $ -1.38M | $ 0 | $ 5.00M |
| 2006 | $ -5.6K | $ -7.80M | $ -799.0K | $ 0 | $ 189.7K |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | -0.83 |
| Liabilities / Eq | -1.18 |
| Current Ratio | 0.21 |

## Other views

- [Metrics](https://sponda.capital/en/IMUC.md)
- [Charts](https://sponda.capital/en/IMUC/charts.md)
- [Compare](https://sponda.capital/en/IMUC/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-30.